FDA Inspection 1208645 — OneBlood - Crestview

OneBlood - Crestview — FEI 3009572488

The FDA completed an inspection of OneBlood - Crestview on May 29, 2023 in Crestview, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 29, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Crestview, FL (United States)